1st Quarter - Report

AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2022 Appropriations for the National Institutes of Health FY 2022 Appropriations for the Centers for Disease Control and Prevention

LobbyistCovered position, as disclosed
DANA MILLER ACTON New —
MARC JOHNSON —
BRANDON LANE LEONARD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Cancer health disparities HPV-related cancers - prevention, screening, diagnosis and treatment HPV vaccination

LobbyistCovered position, as disclosed
DANA MILLER ACTON New —
MARC JOHNSON —
BRANDON LANE LEONARD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Cancer research Oncology product review at the FDA Pediatric research and cancer care

LobbyistCovered position, as disclosed
DANA MILLER ACTON New —
MARC JOHNSON —
BRANDON LANE LEONARD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

Tobacco control measures E-cigarette regulation

LobbyistCovered position, as disclosed
DANA MILLER ACTON New —
MARC JOHNSON —
BRANDON LANE LEONARD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.